Action signal — 🔍 Research

Surfaced by the 2026-10-16 actions digest.

Action: 🔍 Research (LOW) RSI: 13.2

Why this is in actions

Immunovant lost its 200-day last week and fell another leg; the September 23 IMVT-1402 miss is history (October 9 edition). Clinical-stage veto. News last pulled Oct 9, before this week's move. Report listed Nov 9 (provider date).

Trade Summary

Stub — 🔍 Research means more research needed before action.

Sources

• Actions digest: 2026-10-16-actions-daily-digest
• Original row: | **IMVT** | $26.73 | reclaim of the 200-day ($31.91) | **13.2** | **-26.53%** | 53.53% | -16.2% | 2026-10-16 | biotech-scan | 🔍 Research | Immunovant lost its 200-day last week and fell another leg;
• Price truth: summaries